Compliance & Taxes After DEA Registration

The New Rules for Medical Cannabis Businesses

$100 Admission (purchase ticket for Zoom registration)| Free for UNMC & ASA members (RSVP for Zoom registration) 

The DEA registration deadline for state-licensed medical cannabis businesses has passed, but the uncertainty hasn’t.

There have been no meaningful updates from the Department of the Treasury. Rumors and conflicting interpretations continue to circulate about what qualifies as “medical” cannabis, which activities are lawful under federal law, and what the ongoing DEA rescheduling proceedings could mean for the broader cannabis industry.

Meanwhile, businesses that completed the DEA registration process by the deadline are entering a new era of federal recognition and a new world of compliance obligations, tax considerations, and operational questions.

This webinar will examine:

• What DEA registration means for federal and state tax filings
• How federal registration affects the application of Section 280E
• Federal labeling, documentation, and compliance requirements
• Impact of DEA rescheduling proceedings & what’s next
• Federal Policy Update

Join Americans for Safe Access Executive Director Steph Sherer, along with special guests Gail Rand, CPA, of Rand Consulting, and Adam Korenfield, CPA, Tax Partner at CohnReznick, for a practical discussion of the rapidly changing federal policy landscape and what it means for medical cannabis businesses.

Bring your questions—and leave with a clearer understanding of the rules, risks, and opportunities ahead.

This event is organized by Americans for Safe Access & Cannabis Businesses & Professionals United for National Medical Cannabis (UNMC) 

Ticket holders will receive a video link to the webinar.